Wegovy 1.7mg Injection Pen

Description

Wegovy 1.7mg injection pen is a semaglutide-based GLP-1 receptor agonist injection designed for chronic weight management in adults with obesity or overweight conditions. It helps regulate appetite and calorie intake to promote sustainable fat loss.

This dose follows Wegovy 1mg and prepares the body for the final 2.4mg maintenance dose, supporting progressive and well-tolerated treatment results.

Key Features:

• Contains 1.7mg of semaglutide per injection

• Once-weekly, prefilled pen for easy self-administration

• Clinically proven to support weight loss and appetite regulation (NEJM study)

• Part of the gradual Wegovy dosage escalation program

Wegovy 1.7mg Injection Pen Usage Instructions:

• Inject once weekly on the same day each week

• Administer subcutaneously in the abdomen, thigh, or upper arm

• Use this 1.7mg dose after completing the 1mg stage for at least 4 weeks

• Follow your healthcare provider’s dosing schedule

Wegovy 1.7mg Side Effects:

Common side effects may include mild nausea, fatigue, or diarrhea, especially during dose transitions. These symptoms often reduce over time. For more details, refer to the FDA Wegovy Medication Guide.

Storage Instructions:

• Store refrigerated at 36°F–46°F (2°C–8°C)

• Keep in original packaging to protect from light

• Do not freeze